Phase I expansion cohort of TAS-115, a novel oral MET/VEGFR/FMS inhibitor, for castration-resistant prostate cancer patients (CRPC pts) with bone metastases
DOI
オープンアクセス
この論文をさがす
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 28 v274-, 2017-09-01
Elsevier BV